eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
/www.belfasttelegraph.co.uk/news/health/family-slam-health-trust-after-pensioners-undignified-death-36918587.html
. high street chemists across northern ireland are facing closure without an urgent cash injection from health officials, it has been claimed.
.
.
.
.
. ulster nightclub removes offensive billboard of female golfer